Showing 1 - 2 of 2
We evaluate the welfare effects of differential pricing, voluntary licensing, and compulsory licensing in the Indian market for oral anti-diabetic (OAD) drugs. This market includes a new class of molecules called DPP-4 inhibitors, all of which are under patent protection in India. The Indian...
Persistent link: https://www.econbiz.de/10013035611
India surpassed the USA to become the second largest global smartphone market in terms of users in early 2016. India has continued to register strong demand for smartphones to connect hundreds of millions of users to the internet. There is a substantial opportunity for every player in the mobile...
Persistent link: https://www.econbiz.de/10014124146